Metabolism prediction, 3D virtual screening and more – meet StarDrop 7.5
Recording: 3 October 2023
Want to discover next generation drug discovery software? Watch Optibrium’s Chief Scientific Officer Ed Champness to explore the exciting new features in the latest release of StarDrop, built to elevate your drug discovery projects. These include:
- the all-new Metabolism module – access precision modelling to determine Phase I and II metabolic routes, sites, products and lability, and guide compound design to avoid metabolic liabilities
- high performance virtual screening – new Surflex eSim3D capabilities enable you to run virtual screens on millions of compounds on your desktop, fast, getting excellent results in minutes
- additional workflow improvements – including improved 2D structural alignment and easier editing of structures.
Watch the recording
Meet the speaker
CSO AND COMPANY DIRECTOR
After graduating with a degree in Mathematics in 1995 Ed joined GlaxoWellcome working as part of a pioneering team building predictive pharmaceutical tools. He developed the first graphical user-interfaces for working with predictive models which were adopted globally within GlaxoWellcome. He was a core member of the team which established the UK operation of Camitro in 2001 and remained with that company (now operating within BioFocus DPI following merger and acquisition) until 2008. During this time he designed and built the StarDrop software and, in 2009, co-founded Optibrium.